Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Lannett Company, Inc. (the “Company,” “Lannett,” “we,” or “us”) was incorporated in 1942 under the laws of the Commonwealth of Pennsylvania, and reincorporated in 1991 as a Delaware corporation. We develop, manufacture, market and distribute generic versions of branded pharmaceutical products. We report financial information on a quarterly and fiscal year basis with the most recent being the fiscal year ended June 30, 2010. All references herein to a “fiscal year” or “Fiscal” refer to the applicable fiscal year ending June 30. According to data reported by IMS Health in August 2010, we are currently among the top 20 companies, based on number of prescription transactions, for unbranded generic products in the United States. We intend to grow our business organically as well as through strategic partnerships. ... More ...
Analyst Info |
|
| Annual EPS Est: | $0.15 |
| Quarterly EPS Est: | 0.08 |
| PEG Ratio: | 1.40 |
|
Mean Recommendation: View Summary / View All |
1 |
Data is provided by Zacks Investment Research


